about
Role of radionuclide imaging for diagnosis of device and prosthetic valve infectionsPredictors of Ventricular Arrhythmias and Sudden Death in a Québec Cohort With Brugada Syndrome.Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction.Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital.Sudden cardiac death and obesity.Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.Wolff-Parkinson-White as a bystander in a patient with aborted sudden cardiac death.Anticoagulation management pre- and post atrial fibrillation ablation: a survey of canadian centres.Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation.Complex electrograms within the coronary sinus: time- and frequency-domain characteristics, effects of antral pulmonary vein isolation, and relationship to clinical outcome in patients with paroxysmal and persistent atrial fibrillation.Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation.Mechanism of recurrence after radiofrequency catheter ablation of atrial fibrillation guided by complex fractionated atrial electrograms.Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH.The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients.Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.Accuracy of PET/CT for detection of infective endocarditis: Where are we now?Very Late Continued Reverse Remodelling After Cardiac Resynchronization Therapy in Patients With Extreme Left Ventricular Dilatation.Contact-Force Catheters: Efficacy Versus Safety? Case Report of 2 Atrioesophageal Fistulae.Usefulness of cardiac resynchronization therapy in the recovery of patients with left ventricular assist devices.Longitudinal follow-up of Riata leads reveals high annual incidence of new conductor externalization and electrical failure.Extra-anatomic Course of a Right Ventricular Pacing Lead: Clinical Implications.A New Riata Lead Complication: Spontaneous Lead Tip Embolization.PA/Lateral chest X-ray is equivalent to cine-fluoroscopy for the detection of conductor externalization in defibrillation leads.Dynamic left ventricular dyssynchrony and severe mitral regurgitation caused by exercise: should we go beyond the guidelines?2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationA Novel Wearable Device for Continuous Ambulatory ECG Recording: Proof of Concept and Assessment of Signal QualityT-wave oversensing due to left ventricle-only pacing in cardiac resynchronization therapy optimization algorithm.Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrogramsRelationship of frequent postinfarction premature ventricular complexes to the reentry circuit of scar-related ventricular tachycardiaReduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogsAtrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrenceRoles of the left atrial roof and pulmonary veins in the anatomic substrate for persistent atrial fibrillation and ablation in a canine modelHigh-output pacing in mapping of postinfarction ventricular tachycardiaRelationship between the spectral characteristics of atrial fibrillation and atrial tachycardias that occur after catheter ablation of atrial fibrillationProspective comparison between conventional transseptal puncture and transseptal needle puncture with radiofrequency energyUsefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infectionsIsolated potentials and pace-mapping as guides for ablation of ventricular tachycardia in various types of nonischemic cardiomyopathyMapping and ablation of frequent post-infarction premature ventricular complexesRadiofrequency ablation guided by mechanical termination of idiopathic ventricular arrhythmias originating in the right ventricular outflow tract
P50
Q28068781-0AEE1651-9136-40B0-BE3E-51C6CA87134FQ33167377-FD1D06E9-EB72-4F76-97E3-6D96D2BA4852Q37473260-BA43EBE7-3FFA-43B5-87CF-D3B340CD97C8Q37478510-5554CFA2-0198-4ABB-8986-2D6B7D38C0C6Q38243742-F06CC32E-F592-4400-B064-DCEED9A804F9Q40767833-DC426C08-5799-41F3-A4F0-008399292D28Q42288778-B1D1280C-9B19-45D6-8E69-55E6A92E9FEBQ43542426-1D53CD9C-DA30-40A2-9E26-61EE97BA0441Q44625435-7FE7E9F9-77FB-4CD8-8EFE-B3C0BA713952Q46107704-F3BC83A5-8997-4AED-84F3-23D47CB6D37AQ46608084-F668C01E-DD47-4099-9ADC-DFD7FD423456Q46759894-AE3AA860-AE33-4A1C-9EC2-127DC2E039BDQ46878252-A4635C70-DBFD-46BB-BD9A-BE10319F143AQ47562937-CBDB0581-CA0B-4B09-93AB-5DE6FC28502DQ47871557-721D4AA7-26CB-4B87-BCA3-E5D4A6021AA5Q48900667-071D98D0-BE27-47B7-BDD5-34F83BAFD0F7Q49976922-305C9A11-EDDC-40B9-848E-7D388A1B9902Q50622190-47E20B32-4C85-488C-86D4-68C1D34D8FA7Q51190879-02F3D53F-8232-45F5-8494-54B4826829D5Q51192341-6C3950FA-30F2-4B7E-B345-E9446ABFF5A9Q51265281-F6AA6386-1342-47B3-AB2D-26FE319D69B0Q51601041-6ED60D46-C8B2-4437-A063-613F9004E65AQ51787096-B3D41188-6B8F-4A5B-9C93-2DBB6CB1AF74Q53445380-467377FC-1E1B-41A8-92A9-E6B66C6EAFDCQ54946394-FE27B818-CC5E-4D10-855D-7A7D1672C7FCQ58546465-D147D74F-1D92-4DF9-BAA9-6015E2193B6CQ64118045-E17E8834-639F-41E1-BCEA-14FBCF6E04BAQ64984385-81A47B10-9C1A-4689-B52C-B96C8C96B2CCQ80336331-FF82B570-0818-44E2-9875-D94F6A9AB2F2Q80804945-5B6A3235-DB21-4850-8449-27AF95BCFCEBQ81403723-90EF96BC-526C-484F-AB77-8D3A618CFF01Q81506786-4C8C77BB-44A8-46EE-835A-A349A04A0C70Q82427927-ACA4C47C-8F48-4BEC-A96F-12CD82889835Q82977965-C2849DC4-16FA-4A4A-B88B-B4D05DCC2887Q83143482-18CBC51E-98F2-4294-8CD7-DAAC5F4F113AQ83901422-492357BB-120D-4163-9EDB-D6E94484B47EQ84005396-A842B40B-74AC-4920-A1CC-351CD28D807CQ84043227-7FF05625-DEF5-4DAD-8C9B-D8257C28421CQ84194995-3C2E8B28-FC9D-4A59-9BD2-20670E445D71Q84352342-D4FFE3F4-2EB6-4C99-8A71-F178D8E9306D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jean-Francois Sarrazin
@en
Jean-Francois Sarrazin
@nl
type
label
Jean-Francois Sarrazin
@en
Jean-Francois Sarrazin
@nl
prefLabel
Jean-Francois Sarrazin
@en
Jean-Francois Sarrazin
@nl
P31
P496
0000-0002-1114-0661